Meaningful Use is a set of standards defined by the Centers for Medicare and Medicaid Services (CMS) that governs the use of electronic health records and allows eligible providers and hospitals to earn inventive payments by meeting specific criteria. Requirements for meaningful use involve public health reporting criteria. As meaningful use takes a three staged approach, in stage 2 of meaningful use, the following public health objectives apply:
State Public Health Agencies (PHAs) are strongly encouraged to support stage 2 public health objectives. Through meaningful use, public health will be able to respond faster and more effectively to public health events. To help in these efforts, PHAs are publicizing what stage 2 objectives they will support and are creating websites to help share that information. APHL has comprised a list of state specific PHAs stage 2 PH reporting information from those sites. These websites along with their links help eligible professionals and hospitals and other interested entities navigate and find information on state specific public health readiness to receive electronic data.
For state PHA’s, if you have any feedback or any of the information is incomplete or inaccurate, please email Vanessa Holley, Senior Specialist, Informatics, at firstname.lastname@example.org
Will be participating in the national Biosense project for syndormic surveillance
Refer to LHJ MU Capacity Matrix to determine the MU requirement eligible professionals and hospitals want to fulfill http://hie.cdph.ca.gov/lhj-matrix.html
CDPHE will not be supporting SS. However, Denver Public Health and Tri-County Health Department are supporting SS for facilities in their jurisdictions
will accept MUST (meaningful use state testing) portal testing certificates for MU Stage 1 and 2; not ready to continuously accept electronic immunization data submissions
guide for the ELR system will be published July 2015
ready to accept data from cancer cases in 2016
an exclusion will still apply for MU Stage 1 and 2 for ELR and syndromic surveillance data and for Stage 2 reportable cancer cases
Only accepting EP data from urgent care centers
EPs for syndromic surveillance can receive an exemption
will not accept syndromic surveillance data from dentists, podiatrists, optometrists, and chiropractors
The cancer registry is working with IDPH to move forward with this objective. A timeframe has not yet been determined
Requesting information regarding interest in the following specialized registries: Healthy Weight, Chronic Disease
Will be implementing electronic infectious disease case report data into a specialized registry
SS not accepted for all eligible professionals. The cancer registry is under development.
MU exemptions for SS eligible professionals
The cancer registry resides at the University of New Mexico
EHs in NYC report electronic lab results and EPs in NYC report cancer cases to New York State Department of Health.
Currently forming a policy for specialized disease registries
Accepting SS Stage 2 Test data submissions. Additional information will be provided when live messages are able to be accepted
Will not declare readiness for syndromic surveillance until October 2015. Will begin to onboard eligible hospitals wishing to send syndromic surveillance data in preparation for includion in 2015
Plans for a statewide syndromic surveillance system are currently being developed. Some LHDs may do SS
SS for eligible professionals is a case by case basis. Supports requests for contolled substance dispensing data from authorized users.
Please refer to Wisconsin's Public Health Meaningful Use page for more information on readiness.
This page was last modified on 10/6/2015 5:52 PM
Senior Specialist, Informatics
IZ-EH Immunizations for Eligible Hospitals
IZ-EP Immunizations for Eligible Providers
SS-EH Syndromic Surveillance for Eligible Hospitals
SS-EP Syndromic Surveillance for Eligible Providers
RLR Reportable Laboratory Results
CAN Cancer Registry
SPRE Specialized Registry
Association of Public Health Laboratories
Copyright © 2008-2015 All Rights Reserved |